Stifel’s weekly biopharma update, using data from DealForma, provides an update on the biopharma market for the week of October 7, 2024, discussing strong U.S. jobs data, geopolitical tensions, market volatility, a China stimulus, trends in biotech stocks, capital raising activities, and M&A developments ahead of the U.S. presidential election. Check out Stifel’s report.
